Parse Biosciences vs. 10x Genomics, Inc.

Explore the PTAB proceeding IPR2023-00876 filed by Parse Biosciences on 2023-04-20. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2023-00876

Filing Date

2023-04-20

Accorded Filing Date

2023-04-20

Institution Decision Date

2023-10-13

Last Modified Date

2025-05-05

Proceeding Type

IPR

Termination Date

2024-09-17

Trial Status

Final Written Decision - Appealed

Parties & Counsel

Petitioner

Parse Biosciences

Represented By

Walter, Dereket al

Patent Owner / Respondent

10x Genomics, Inc.

Represented By

Baughman, Jonet al

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Patent Information

1 Patent Involved

Respondent Application Number 15677957

Respondent Patent Number 10155981

External Links

Espacenet

Google Patents

Respondent Inventor Sydney Brenner et al

Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Address and Attorney/Agent Information

22 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name Morgan, Lewis & Bockius LLP (SF)

Customer Number 43850

Address 600 Montgomery Street, Suite 2300, San Francisco, CA, 94111, UNITED STATES

Attorney / Agent Information

Reg #	Name	Phone
42813	Brett Lovejoy	415-442-1211
42837	Jeffry Mann	415-442-1000
58729	Louis-Vu Nguyen	415-442-1303
58752	John Hemmer	215-963-4816
59098	Zara Doddridge	415-273-7514
60711	Richard Leung	215-963-5082
65210	Christina Macdougall	415-442-1277
65346	Randy Wu	415-503-7895
67702	Brett Schweers	773-697-9088
68477	Inna Dahlin	467-338-11550
70871	Andrew Antczak	215-963-5000
72612	Robert Piston	402-559-2182
73759	Jeffrey Bolland	205-470-6077
74740	Jason Schultz	925-401-7300
75415	Hiu Lau	858-314-5439
75553	Carmen Chow	212-497-7739
75615	Cristina Wittkopp	206-202-8946
75962	Jacque Caprio	865-643-3044
78072	Conor Ball	415-442-1668
79300	Evelyn Chou	415-442-1609
80099	Courtney Jn Baptiste	404-879-2168
81262	Samuel Locascio	925-694-2476

Proceeding Documents

144

Petitioner Parse Biosciences, Inc.'s Supplemental Power of Attorney for Concord Cheung NOTICE

2025-05-05 FILING PARTY: PETITIONER

Download

Petitioner Parse Biosciences, Inc.'s Supplemental Mandatory Notice Adding Backup Counsel Under 37 C.F.R. Section 42.8(a)(3) NOTICE

2025-05-05 FILING PARTY: PETITIONER

Download

Patent Owner's Notice of Appeal NOTICE

2024-11-15 FILING PARTY: PATENT OWNER

Download

Final Written Decision: original FINAL

2024-09-17 FILING PARTY: BOARD

Download

Other: Hearing transcript OTHER

2024-08-13 FILING PARTY: BOARD

Download

Parse Biosciences vs. 10x Genomics, Inc.

Proceeding Overview

Parties & Counsel

Petitioner

Parse Biosciences

Represented By

Patent Owner / Respondent

10x Genomics, Inc.

Represented By

Tribunal & Venue

Patent Information

Address and Attorney/Agent Information

Power of Attorney & Correspondence

Attorney / Agent Information

Proceeding Documents

Petitioner Parse Biosciences, Inc.'s Supplemental Power of Attorney for Concord Cheung NOTICE

Petitioner Parse Biosciences, Inc.'s Supplemental Mandatory Notice Adding Backup Counsel Under 37 C.F.R. Section 42.8(a)(3) NOTICE

Patent Owner's Notice of Appeal NOTICE

Final Written Decision: original FINAL

Other: Hearing transcript OTHER

Patent Owner's Submission of Unresolved Objections to Petitioner's Demonstratives OTHER

Petitioner's Objections to Patent Owner's Demonstratives OTHER

Patent Owner 10x Genomics, Inc.’s Demonstrative Slides OTHER

Petitioner Parse Biosciences, Inc.'s Oral Argument Demonstrative OTHER

Patent Owner's Reply in Support of its Motion to Exclude OTHER

Petitioner's Reply to Patent Owner's Opposition to Motion to Exclude REPLY

Patent Owner's Supplemental Paper Regarding Quakenbush Report Excerpt OTHER

Patent Owner's Opposition to Petitioner's Motion to Exclude OTHER

EX1068 Exhibit

Petitioner’s Opposition to Patent Owner’s Motion to Exclude OPPOSITION

EX1067 Exhibit

Petitioner's Supplemental Paper In Support Of Submission Of Dr. Quackenbush Report Excerpt NOTICE

Petitioner's Motion to Exclude MOTION

Patent Owner's Motion to Exclude MOTION

ORDER Conduct of the Proceeding 37 C.F.R. § 42.5 ORDER

Setting Oral Argument 37 C.F.R. § 42.70 ORDER

Patent Owner's Request for Oral Hearing OTHER

Petitioner’s Supplemental Paper Regarding Why Petitioner’s Arguments Are Not New Or Improper OTHER

EX1066 Exhibit

Patent Owner's Objections to Evidence OTHER

Petitioner’s Objections To Evidence Under 37 C.F.R. § 42.64 OTHER

Petitioner’s Request For Oral Argument Pursuant To 37 C.F.R. § 42.70(a) OTHER

EX2020 - May 2, 2024 Deposition Transcript of Gregory Cooper, Ph.D. Exhibit

EX2103 - V. Llorens-Rico et al, Single-cell approaches in human microbiome research, Cell (2022) 185:2725 (marked as EX2103 in Dr. Cooper’s May 2, 2024 deposition (EX2020)) Exhibit

EX2021 - Parse Biosciences, Inc. v. 10x, Genomics Inc., IPR2023-00955, Pap.1 (May 25, 2023) Exhibit

EX2101 - S. Guan, A. Blanchard, P. Zhang, & Z. Zhu, Alteration of Sequence Specificity of the Type IIS Restriction Endonuclease BtsI, (July 26, 2010) (marked as EX2101 in Dr. Cooper’s May 2, 2024 deposition (EX2020)) Exhibit

Patent Owner's Sur-Reply OTHER

EX2105 - S. Slomovic et al., RNA Polyadenylation in Prokaryotes and Organelles; Different Tails Tell Different Tales, Critical Revs. In Plant Scis. (2006) 25:65-77 (marked as EX1068 in Dr. Cooper’s May 2, 2024 deposition (EX2020)) Exhibit

EX2104 - N. Sarkar, Polyadenylation of mRNA in Prokaryotes, Annu. Rev. Biochem (1997) 66:173-97 (marked as EX1067 in Dr. Cooper’s May 2, 2024 deposition (EX2020)) Exhibit

Patent Owner’s Authorized Supplemental Paper Identifying Exemplary New and Improper Arguments and Theories in Petitioner’s Reply and Related Papers OTHER

EX2023 - Parse Biosciences, Inc. v. 10x Genomics, Inc. IPR2023-00955, EX1002 (Apr. 20, 2023) (Declaration of Gregory Cooper, Ph.D.) Exhibit

EX2102 - C. Wansgasnuwat et al, Efficient and cost-effective bacterial mRNA sequencing from low input samples through ribosomal RNA depletion, BMC Genomics (2020) 21:717 (marked as EX2102 in Dr. Cooper’s May 2, 2024 deposition (EX2020)) Exhibit

Deposition Notice of Gregory Cooper, Ph.D. NOTICE

Patent Owner's Objections to Evidence OTHER

EX1063 Exhibit

EX1064 Exhibit

EX1058 Exhibit

Petitioner's Reply to Patent Owner's Response REPLYTOOPP

EX1065 Exhibit

EX1062 Exhibit

EX1057 Exhibit

EX1059 Exhibit

EX1061 Exhibit

EX1060 Exhibit

ORDER Granting Petitioner’s Motions for Pro Hac Vice Admission of Edward R. Reines 37 C.F.R. § 42.10 ORDER

PETITIONER PARSE BIOSCIENCES, INC.’S NOTICE OF DEPOSITION OF JOHN QUUACKENBUSH NOTICE

Exhibit 1055 - In re Reines Federal Circuit decision, 14-MA0004 Exhibit

Petitioner Parse Biosciences, Inc.'s Motion for Admission Pro Hac Vice of Edward R. Reines Pursuant to 37 C.F.R. Section 42.10 MOTION

Petitioner Parse Biosciences, Inc.'s Updated Exhibit List NOTICE

Exhibit 1054 - Declaration of Edward R. Reines in support of pro hac vice motion Exhibit

Petitioner Parse Biosciences, Inc.'s Supplemental Power of Attorney for Edward R. Reines NOTICE

Exhibit 1056 - Personal Statement of Edward R. Reines, Fed. Cir. 14-MA004 Exhibit

Petitioner Parse Biosciences, Inc.'s Supplemental Mandatory Notice Adding Backup Counsel Under 37 C.F.R. Section 42.8(a)(3) NOTICE

Panel Change Order ORDER

EX2013 - Declaration of John Quackenbush, Ph.D. (Corrected) Exhibit

EX2016 - Piovesan et al., On the length, weight, and GT content of the human genome, BMC Res. Notes 12:106 (2019) (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391780/#:~:text=Considering%20a%20mean%20weight%20in,units%2Fcarat.htm) Exhibit

EX2018 - Deposition Transcript of Gregory Cooper, Ph.D. Exhibit

EX2011 - Parse Biosciences, Inc. v. 10x, Genomics Inc., IPR2023-00958, EX1002 (May 25, 2023) (Declaration of Gregory Cooper, Ph.D) Exhibit

EX2012 - Parse Biosciences, Inc. v. 10x, Genomics Inc., IPR2023-00958, EX1054 (May 25, 2023) (Georgi K. Marinov et al., From single-cell to cell-pool transcriptomes: Stochasticaly in gene expression and RNA splicing, 24.3 Genome Research 496-510 (2014) (“Marinov”)) Exhibit

EX2013 - Declaration of Dr. John Quackenbush Exhibit